Healthpeak Properties (NYSE:DOC) Issues Earnings Results, Beats Estimates By $0.01 EPS

Healthpeak Properties (NYSE:DOC) released its quarterly earnings data on Thursday. The real estate investment trust reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.01, Zacks reports. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm had revenue of $705.87 million for the quarter, compared to analysts’ expectations of $681.65 million. During the same period in the prior year, the firm posted $0.45 earnings per share. The firm’s quarterly revenue was up .8% on a year-over-year basis. Healthpeak Properties updated its FY 2025 guidance to 1.810-1.870 EPS.

Healthpeak Properties Stock Down 0.4%

Healthpeak Properties stock opened at $18.54 on Friday. Healthpeak Properties has a twelve month low of $16.63 and a twelve month high of $23.26. The stock’s fifty day simple moving average is $18.29 and its 200-day simple moving average is $17.90. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $12.89 billion, a P/E ratio of 77.27, a P/E/G ratio of 3.17 and a beta of 1.09.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Friday, December 19th. This represents a c) dividend on an annualized basis and a dividend yield of 6.6%. Healthpeak Properties’s dividend payout ratio is currently 508.33%.

Insider Buying and Selling at Healthpeak Properties

In related news, CEO Scott M. Brinker acquired 1,490 shares of the business’s stock in a transaction dated Monday, August 4th. The shares were acquired at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the transaction, the chief executive officer owned 211,906 shares of the company’s stock, valued at $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders acquired a total of 8,783 shares of company stock worth $150,129 over the last 90 days. 0.23% of the stock is currently owned by corporate insiders.

Institutional Trading of Healthpeak Properties

A number of large investors have recently modified their holdings of DOC. Integrated Wealth Concepts LLC increased its holdings in Healthpeak Properties by 7.3% in the first quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after buying an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock valued at $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP increased its holdings in Healthpeak Properties by 41.3% in the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after buying an additional 17,279 shares during the last quarter. Brown Advisory Inc. increased its holdings in Healthpeak Properties by 3.1% in the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after buying an additional 1,415 shares during the last quarter. Finally, Qube Research & Technologies Ltd purchased a new position in Healthpeak Properties in the second quarter valued at $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

DOC has been the topic of a number of recent analyst reports. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a report on Monday, September 15th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Morgan Stanley cut their target price on Healthpeak Properties from $22.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, August 22nd. Robert W. Baird set a $21.00 target price on Healthpeak Properties and gave the company an “outperform” rating in a research report on Wednesday, July 30th. Finally, Cantor Fitzgerald began coverage on Healthpeak Properties in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 target price on the stock. Eight investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $21.33.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.